Key Terms
Authors
Edward M. Saito, PharmD, BCACP; John Begert, PharmD, BCACP; Brandon Nuziale, PharmD, BCACP; Vivian Chau, PharmD; Miranda
Domain
Health Promotion / Disease Prevention
Three pillars
1. Lifestyle modifications 2.
Evidence of Pharmacist Impact
Pharmacist involvement has shown improved outcomes in:
Definition
A collaborative process in which the clinician and patient work together to make healthcare decisions that align with th
Social determinants of health
The conditions in which people are born, grow, live, work, and age that affect health outcomes.
Glipizide mechanism
Sulfonylurea; stimulates pancreatic insulin release independent of blood glucose level.
SCr
Increased from 0.8 to 1.2 mg/dL over 9 months — rising trend; still within normal but moving in the wrong direction; ind
TG
361 mg/dL — severely elevated (normal 0-149 mg/dL); highly elevated TG is a cardiovascular risk factor and may be worsen
HDL
29 mg/dL — very low (goal ≥50 mg/dL); low HDL compounds cardiovascular risk
LDL
52 mg/dL — within normal range; currently not the primary lipid concern for this patient
ROS findings
Polyuria (frequent urination), polydipsia (excessive thirst), numbness in fingers (peripheral neuropathy) — classic DM s
Vitals
BP 130/78 mmHg; HR 90 bpm
Diabetes Mellitus (DM)
Chronic metabolic condition affecting blood glucose regulation
Gestational Diabetes
DM developing during pregnancy